Stonegate Investment Group, LLC Vertex Pharmaceuticals Inc Transaction History

Stonegate Investment Group, LLC

$3.67 Billion
Q3 2024

A detailed history of Stonegate Investment Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Stonegate Investment Group, LLC holds 6,468 shares of VRTX stock, worth $3.25 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,468

Previous 6,742 4.06%

Holding current value

$3.25 Million

Previous $3.16 Million 4.81%

% of portfolio

0.08%

Previous 0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$460.0 - $505.78 $126,040 - $138,583	-274 Reduced 4.06%	6,468 $3.01 Million
Q2 2024 Aug 02, 2024	BUY	$392.81 - $485.53 $1.41 Million - $1.75 Million	3,598 Added 114.44%	6,742 $3.16 Million
Q1 2024 Apr 22, 2024	SELL	$407.69 - $446.08 $53,815 - $58,882	-132 Reduced 4.03%	3,144 $1.31 Million
Q4 2023 Jan 23, 2024	SELL	$343.0 - $410.68 $52,822 - $63,244	-154 Reduced 4.49%	3,276 $1.33 Million
Q3 2023 Oct 24, 2023	SELL	$338.18 - $362.46 $132,566 - $142,084	-392 Reduced 10.26%	3,430 $1.19 Million
Q2 2023 Jul 26, 2023	SELL	$314.42 - $351.91 $943 - $1,055	-3 Reduced 0.08%	3,822 $1.35 Million
Q1 2023 Apr 20, 2023	SELL	$283.23 - $323.1 $133,118 - $151,857	-470 Reduced 10.94%	3,825 $1.21 Million
Q4 2022 Jan 24, 2023	SELL	$285.76 - $321.48 $12,573 - $14,145	-44 Reduced 1.01%	4,295 $0
Q3 2022 Oct 28, 2022	SELL	$273.83 - $305.53 $101,317 - $113,046	-370 Reduced 7.86%	4,339 $1.26 Million
Q2 2022 Aug 09, 2022	SELL	$234.96 - $292.55 $116,070 - $144,519	-494 Reduced 9.49%	4,709 $1.33 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $120,452 - $141,967	-544 Reduced 9.47%	5,203 $1.36 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $1.02 Million - $1.28 Million	5,747 New	5,747 $1.26 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonegate Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonegate Investment Group, LLC with notifications on news.

Account

Stonegate Investment Group, LLC Vertex Pharmaceuticals Inc Transaction History